Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone

• Status: Completed
• Trial end date: 2012-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether low-dose combine oral contraceptives (COC) containing desogestrel 150 mg and drospirenone 3 mg are effective in the treatment of Premenstrual symptoms.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Chulalongkorn University
• Treatments: Contraceptive Agents; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Drospirenone; Estradiol; Estradiol 17 beta-cypionate; Estradiol 3-benzoate; Estradiol valerate; Ethinyl Estradiol; Hormones; Polyestradiol phosphate

Criteria

Inclusion Criteria:

• age 18-35years

• Regular menses, I:21-35 days

• Willingness to take COC for 6 months

• No history of COC in last 6 months

• No history of injected contraception in last 6 months

• History of implant contraception need to have regular menses 3 cycles

• History of miscarriage need to have regular menses 3 cycles

Exclusion Criteria:

• Pregnant or suspected pregnant

• Breast feeding

• Smoking

• Contraindication of WHO 2,3 and 4

• PMDD